Eyenovia, Inc. (EYEN) stock declined over -16.85%, trading at $2.27 on NASDAQ, down from the previous close of $2.73. The stock opened at $2.56, fluctuating between $2.22 and $2.60 in the recent session.
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the development of therapeutic indications for patients with progressive myopia and age-related near vision impairment or presbyopia indications; and microdose fixed combination ophthalmic pharmaceutical for mydriasis to address the eye exams with pupil dilation. The company's product candidates include MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); and MydCombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; and a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine and MicroLine in China and South Korea. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is headquartered in New York, New York.
Employees | 57 |
Beta | 1.75 |
Sales or Revenue | $3.79K |
5Y Sales Change% | 0% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Biotechnology |
Eyenovia, Inc. (NASDAQ: EYEN) stock price is $2.27 in the last trading session. During the trading session, EYEN stock reached the peak price of $2.60 while $2.22 was the lowest point it dropped to. The percentage change in EYEN stock occurred in the recent session was -16.85% while the dollar amount for the price change in EYEN stock was -$0.46.
The NASDAQ listed EYEN is part of Biotechnology industry that operates in the broader Healthcare sector. Eyenovia, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Bren Kern
Senior Vice President of Manufacturing & Operations
Mr. John P. Gandolfo CPA
Chief Financial Officer & Sec.
Alexander Lobo
Investor Contact
Dr. Tsontcho Ianchulev M.D., M.P.H., MPH
Co-Founder & Executive Chairman
Mr. Michael M. Rowe
Chief Executive Officer & Director
EYEN's closing price is 15.48% higher than its 52-week low of $2.22 where as its distance from 52-week high of $205.60 is -98.67%.
Number of EYEN employees currently stands at 57.
Official Website of EYEN is: https://www.eyenovia.com
EYEN could be contacted at phone 917 289 1117 and can also be accessed through its website. EYEN operates from 295 Madison Avenue, New York, NY 10017, United States.
EYEN stock volume for the day was 183.69K shares. The average number of EYEN shares traded daily for last 3 months was 346.93K.
The market value of EYEN currently stands at $3.16M with its latest stock price at $2.27 and 1.39M of its shares outstanding.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com